Takeda Biotech JV to Focus on 8 Projects for Now, Eyes IPO: CEO Okumura

March 15, 2017
Scohia Pharma CEO Yoichi Okumura Scohia Pharma, a biotech joint venture formed by Takeda Pharmaceutical with two partners, will initially focus on eight renal, metabolic, and cardiovascular projects taken over from the drug juggernaut, while looking at an IPO after...read more